What is Protekx?
Protekx operates as a specialized manufacturer and distributor of high-performance personal protective equipment (PPE). The company's product portfolio is comprehensive, encompassing 3-ply procedural masks, N95 respirators, gloves, face shields, goggles, and full-body protective suits. By integrating professional design expertise with the manufacturing prowess of Ever Win International Corp., Protekx has positioned itself as a vital supplier for front-line workers and institutional clients. The company's core mission is to mitigate the risks posed by germs, viruses, and biological agents through durable, high-value equipment. Their market strategy focuses on long-term sustainability, ensuring that both current and future global health requirements are met with consistent, high-quality production standards.
How much funding has Protekx raised?
Protekx has raised a total of $675K across 2 funding rounds:
Debt
$350K
Debt
$325K
Debt (2020): $350K with participation from PPP
Debt (2021): $325K led by PPP
Key Investors in Protekx
PPP
Public-Private Partnership
What's next for Protekx?
Looking ahead, Protekx is poised to leverage its recent capital influx to optimize its global supply chain and expand its footprint in key international markets. The strategic focus will likely shift toward diversifying its product line and enhancing manufacturing throughput to maintain a competitive edge in the PPE industry. As the global landscape for health security evolves, Protekx is well-positioned to capitalize on the growing demand for institutional-grade protective gear. The company's ability to maintain consistent production cycles, supported by its robust financial backing, suggests a trajectory of sustained growth and operational stability. Future initiatives will likely involve further integration of advanced materials and the strengthening of distribution networks to ensure rapid deployment of protective assets in high-need regions.
See full Protekx company page
